A method of inducing high anti-leukemia activity responsive to the combination of hydroxamic acid analogue histone deacetylase inhibitors and PKC412 against human acute leukemia characterized as expressing phosphorylated (p)FLT3 kinase by a novel flow cytometry-based assay.
Bhalla, Kapil N., "Leukemia treatment method and composition" (2010). USF Patents. 493.
University of South Florida